Article
Panel members are asked to discuss what drives the cost of drugs in cancer care. They also discuss the role companion diagnostics and personalized medicine play in oncology.
Lurbinectedin Plus Atezolizumab Maintenance Shows Improved Survival vs Atezolizumab in SCLC
Varied Access: The Pharmacogenetic Testing Coverage Divide
HHS Sets Pricing Target for Trump’s Most Favored Nation Drug Price Model
Telemedicine’s Evolution and Expanding Access to Obesity, Specialty Care
Is the US Headed for an Infectious Disease Pandemic?
Novel, Noninvasive Skin Cancer Detection Method Shows Promise